caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1013178094

Melissa MartinM.D.

PRACTICENEWH OBGYN, LLCSee all providers at this practice →
Obstetrics & GynecologyWoburn, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 220105
Hospital
REFERRAL NETWORK

Where Melissa Martin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
1123
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
WINCHESTER HOSPITAL2486
LAWRENCE GENERAL HOSPITAL1223
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
11
Beneficiaries
—
Total drug cost
$347
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Estradiol11 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
61
Unique beneficiaries
—
Total services
66
Distinct HCPCS
2
Medicare payment
$4K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 671 Obstetrics & Gynecology providers in MA — below median (cohort median 113).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.